Results 151 to 160 of about 73,633 (314)

Losartan: a pharmacoeconomic review

Journal of Medical Economics, 2007
SummaryThe angiotensin II antagonist losartan has been clinically studied in several patient populations including type 2 diabetes mellitus (T2DM) with nephropathy, hypertension with left ventricular hypertrophy, and the elderly with heart failure. The aim of this paper is to provide a review of the health economic evaluations based on the clinical ...
openaire   +2 more sources

‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis

BJU International, Volume 136, Issue 1, Page 38-41, July 2025.
Lu Dongming, Ye Shuchao, Xie Xueping, Zheng Luoping, Liao Shangfan, Wu Yongyang   +5 more
wiley   +1 more source

A024 Candesartan causes a long-lasting antagonism of the angiotensin II receptor mediated contractile effects in isolated vascular preparations: A comparison with losartan and its active metabolite (EXP 3174) [PDF]

, 1998
Tommy Abrahamsson
openalex   +1 more source

E059 Long term blood pressure control with losartan alone or in combination with hydrochlorothiazide or other antihypertensive drugs in patients with mild to moderate essential hypertension [PDF]

, 1998
AURUP
openalex   +1 more source

Candesartan vs losartan [PDF]

Journal of Human Hypertension, 1998
A Dumaswala, T Bunt
openaire   +2 more sources

Effects of Losartan on Capillary Density in Cardiac Muscles of Diabetic Rats

مجله دانشکده پزشکی اصفهان, 2012
Background: Stimulatory and/or inhibitory effects of angiotensin II is attributed to angiotensin receptor I. A few studies investigated the role of angiotensin receptor I on cardiovascular system in diabetic subjects.
Ali Reza Fallahzadeh, Noushin Afsharmoghaddam, Majid Khazaei   +2 more
doaj  

B029 The effects of angiotensin II antagonist losartan on urinary albumin excretion in non insulin-dependent diabetes mellitus [PDF]

, 1998
P. D. Ragonesi
openalex   +1 more source

Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update

Nephrology, Volume 30, Issue S2, Page 3-56, July 2025.
Adrian Liew, Sunita Bavanandan, Chuan‐Ming Hao, Soo Kun Lim, Narayan Prasad, Manisha Sahay, Paweena Susantitaphong, Veena Roberts, Eranga Wijewickrama, Muh Geot Wong, Sydney C. W. Tang   +10 more
wiley   +1 more source

Losartan Normalizes Endothelium-Derived Hyperpolarizing Factor–Mediated Relaxation by Activating Ca2+-Activated K+ Channels in Mesenteric Artery From Type 2 Diabetic GK Rat

Journal of Pharmacological Sciences, 2010
Ca2+-activated K+ (K Ca ) channels are important for endothelium-derived hyperpolarizing factor (EDHF) signaling. Since treatment with angiotensin II receptor blockers (ARBs) improves vasculopathies in type 2 diabetic patients, we asked whether the EDHF ...
Takayuki Matsumoto, Keiko Ishida, Kumiko Taguchi, Tsuneo Kobayashi, Katsuo Kamata   +4 more
doaj  

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats

Journal of Applied Oral Science
Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats.
Gabriel Mulinari-Santos, Jaqueline Silva dos Santos, Letícia Pitol Palin, Ana Cláudia Ervolino da Silva, Cristina Antoniali, Leonardo Perez Faverani, Roberta Okamoto   +6 more
doaj   +1 more source